Looks unlikely that there will be any last minute "surprises barring postponement by FDA to original NDA timeline - which seems unlikely. Sales force ready to go, but I expect there will be more hospital-initiated requests than they anticipate, especially from same-day outpatient surgery centers (which they hardly ever mention).

I stick by 60% chance (my estimate of NDA on 11-13-09) for 600% gain (my estimate using 90M vials annually with P/E of 12) over 6 years (the amount of years until steady-state market).

Double current price with + FDA, 50% current price with FDA postponement/


EB